ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling

This study has been completed.

Sponsored by: National Human Genome Research Institute (NHGRI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00056186
  Purpose

The purposes of this study are to learn about significant life changes for people with Friedreich's ataxia and about patients' experiences with health care providers. Friedreich's ataxia is a rare genetic disorder in which patients experience progressive muscle weakness and loss of coordination in the arms and legs. They may have other complications, such as vision and hearing impairment, dysarthria, scoliosis, diabetes, and heart disease. The study will explore the impact of this chronic progressive illness on transitional life events, such as career choice and marriage, and the role of family members and health care providers-particularly genetic counselors-in helping patients progress through these events.

Patients with Friedreich's ataxia who are 18 years of age or older may be eligible for this study. Those enrolled will participate in a 45- to 60-minute interview by phone or in person, in which they will be asked questions about important changes in their lives and their past experiences with health care providers. The interview will be audiotaped.


Condition
Friedreich Ataxia

Genetics Home Reference related topics:   familial encephalopathy with neuroserpin inclusion bodies    Friedreich ataxia    mitochondrial neurogastrointestinal encephalopathy disease   

MedlinePlus related topics:   Friedreich's Ataxia    Genetic Counseling   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Exploration of Transitional Life Events in Individuals With Friedreich's Ataxia: Implications for Genetic Counseling

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   40
Study Start Date:   March 2003
Estimated Study Completion Date:   January 2004

Detailed Description:

Human development across the lifespan is a process of continual change, adaptation and growth. Throughout this process, key transitional events, such as career choice and marriage, mark important points in time when an individual's life course is significantly altered. These transitional events may be instigated by age, historical or idiosyncratic factors. Of particular interest in the present study are patients' perceptions of transitional events brought about or altered by chronic illness and disability. Additionally, factors (i.e. social support, communication, family) that help facilitate progression through these events will be investigated. The actual or potential role of health care providers during transitional events will also be explored with a specific emphasis on genetic counseling. These themes will be examined through the administration of a one-time, semi-structured, in-person or telephone interview of patients with Friedreich's ataxia: a progressive, debilitating, neurodegenerative condition. The interviews will be approximately 45-60 minutes in length and will include open-ended questions to elicit qualitative data. Approximately 40 subjects will be recruited from Friedreich's ataxia support groups, a research organization and a clinical setting.

It is anticipated that data elicited from the study will lead to recommendations regarding the process and content of genetic counseling for individuals with Friedreich's ataxia. These considerations, coupled with qualitative data obtained from participants, may also have implications for the evolving role of the genetic counselor. Specifically, consideration of developmental counseling approaches, which emphasize key transitional events, may be particularly useful as genetic counselors become increasingly involved in subspecialties (i.e. cardiology, pediatrics, neurology) that provide continuing follow-up care to patients.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

INCLUSION CRITERIA:

Any individual diagnosed with Friedreich's ataxia, 18 years of age or older, who speaks English and is either in attendance at the NAF conference, or who has access to a telephone.

EXCLUSION CRITERIA:

Adolescents and children under the age of 18. Children and adolescents will be excluded due to the potiential for increased psychological and/or emotional.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00056186

Locations
United States, Maryland
National Human Genome Research Institute (NHGRI)    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
  More Information


Publications:

Study ID Numbers:   030118, 03-HG-0118
First Received:   March 7, 2003
Last Updated:   March 3, 2008
ClinicalTrials.gov Identifier:   NCT00056186
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Adaptation  
Neurodegenerative  
Health Care Provider  
Psychosocial  
Chronic Illness/Disability  
Friedreich's Ataxia
Friedreich's Ataxia
Friedreich Ataxia
FA

Study placed in the following topic categories:
Metabolic Diseases
Spinal Cord Diseases
Central Nervous System Diseases
Mitochondrial Diseases
Brain Diseases
Neurodegenerative Diseases
Dyskinesias
Signs and Symptoms
Heredodegenerative Disorders, Nervous System
Genetic Diseases, Inborn
Friedreich Ataxia
Friedreich ataxia
Ataxia
Neurologic Manifestations
Chronic Disease
Metabolic disorder
Cerebellar Diseases
Spinocerebellar Degenerations

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on November 30, 2008




Links to all studies - primarily for crawlers